skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Dendritic Cell-CEA Peptide Vaccine (Code C2473)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Dendritic Cell-CEA Peptide Vaccine

Definition: A cancer vaccine consisting of dendritic cells harvested from a patient with cancer and pulsed or transduced with a peptide fragment of carcinoembryonic antigen (CEA), a tumor-associated antigen expressed by a wide range of cancers. When the altered dendritic cells are returned to the patient, they may stimulate the host immune system to mount a cytotoxic T-lymphocyte immune response against tumor cells expressing CEA.

Label: Dendritic Cell-CEA Peptide Vaccine

NCI Thesaurus Code: C2473 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C0678037  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
CEA peptide-pulsed DC vaccine
CEA peptide-pulsed dendritic cell vaccine
Dendritic cell-carcinoembryonic antigen peptide vaccine
Dendritic Cell-CEA Peptide Vaccine
Dendritic Cell CEA Peptide Vaccine
peptide vaccine, dendritic cell-CEA
Vaccine, dendritic cell-CEA peptide

External Source Codes: 
PDQ Closed Trial Search ID 43031
PDQ Open Trial Search ID 43031 (check for NCI PDQ open clinical trial info)
UMLS CUI C0678037

Other Properties:
     Name Value (qualifiers indented underneath)
code C2473
Legacy_Concept_Name Dendritic_Cell_CEA_Peptide_Vaccine
Semantic_Type Immunologic Factor
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom